BioMarin's Gene Therapy for Hemophilia Could Gain European Approval at the End of August ... - Latest Tweet by Bloomberg

BioMarin's gene therapy for hemophilia could gain European approval at the end of August after getting a key recommendation in June from a regulatory committee, according to the company's chief commercial officer https://t.co/faALvL01Sl— Bloomberg (@business) July 20, 2022

(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)